212 related articles for article (PubMed ID: 20561401)
41. The role of asparagine synthetase on nutrient metabolism in pancreatic disease.
Tsai CY; Kilberg MS; Husain SZ
Pancreatology; 2020 Sep; 20(6):1029-1034. PubMed ID: 32800652
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.
Yu Q; Wang X; Wang L; Zheng J; Wang J; Wang B
Scand J Gastroenterol; 2016 Oct; 51(10):1220-6. PubMed ID: 27251594
[TBL] [Abstract][Full Text] [Related]
43. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
[TBL] [Abstract][Full Text] [Related]
44. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
Ikeuchi H; Ahn YM; Otokawa T; Watanabe B; Hegazy L; Hiratake J; Richards NG
Bioorg Med Chem; 2012 Oct; 20(19):5915-27. PubMed ID: 22951255
[TBL] [Abstract][Full Text] [Related]
45. ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase.
Williams RT; Guarecuco R; Gates LA; Barrows D; Passarelli MC; Carey B; Baudrier L; Jeewajee S; La K; Prizer B; Malik S; Garcia-Bermudez J; Zhu XG; Cantor J; Molina H; Carroll T; Roeder RG; Abdel-Wahab O; Allis CD; Birsoy K
Cell Metab; 2020 Apr; 31(4):852-861.e6. PubMed ID: 32268116
[TBL] [Abstract][Full Text] [Related]
46. Asparagine synthetase: Function, structure, and role in disease.
Lomelino CL; Andring JT; McKenna R; Kilberg MS
J Biol Chem; 2017 Dec; 292(49):19952-19958. PubMed ID: 29084849
[TBL] [Abstract][Full Text] [Related]
47. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.
Chien WW; Le Beux C; Rachinel N; Julien M; Lacroix CE; Allas S; Sahakian P; Cornut-Thibaut A; Lionnard L; Kucharczak J; Aouacheria A; Abribat T; Salles G
Sci Rep; 2015 Jan; 5():8068. PubMed ID: 25626693
[TBL] [Abstract][Full Text] [Related]
48. Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
Pan Y; Suzuki T; Sakai K; Hirano Y; Ikeda H; Hattori A; Dohmae N; Nishio K; Kakeya H
Eur J Pharmacol; 2023 Dec; 960():176156. PubMed ID: 38059445
[TBL] [Abstract][Full Text] [Related]
49. Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate.
Worton KS; Kerbel RS; Andrulis IL
Cancer Res; 1991 Feb; 51(3):985-9. PubMed ID: 1703043
[TBL] [Abstract][Full Text] [Related]
50. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
[TBL] [Abstract][Full Text] [Related]
51. Asparagine synthetase: regulation by cell stress and involvement in tumor biology.
Balasubramanian MN; Butterworth EA; Kilberg MS
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E789-99. PubMed ID: 23403946
[TBL] [Abstract][Full Text] [Related]
52. Role of asparaginase synthetase and asparagyl-transfer RNA synthetase in the cell-killing activity of asparaginase in Chinese hamster ovary cell mutants.
Waye MM; Stanners CP
Cancer Res; 1981 Aug; 41(8):3104-6. PubMed ID: 6113889
[TBL] [Abstract][Full Text] [Related]
53. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
54. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
[TBL] [Abstract][Full Text] [Related]
55. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
Aslanian AM; Kilberg MS
Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
[TBL] [Abstract][Full Text] [Related]
56. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
Majlessipour F; Kwock R; Martin-Aragon S; Weinberg KI; Avramis VI
Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
[TBL] [Abstract][Full Text] [Related]
58. A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.
Ikeuchi H; Meyer ME; Ding Y; Hiratake J; Richards NG
Bioorg Med Chem; 2009 Sep; 17(18):6641-50. PubMed ID: 19683931
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of the anti-leukemia effect and mechanism of L-asparaginase between two different strains].
Wang KM; Xu HG; Guo HX; Jin SW; Luo XQ; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):692-7. PubMed ID: 24989278
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines.
Ding Y; Li Z; Broome JD
Leukemia; 2005 Mar; 19(3):420-6. PubMed ID: 15674423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]